EDITORIAL
Published on 16 May 2023
Editorial: Nanobody-based cancer immunotherapy and immunoimaging
doi 10.3389/fimmu.2023.1213386
- 1,821 views
- 2 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Nanobody-based Cancer Immunotherapy and Immunoimaging
Nanobody-based Cancer Immunotherapy and Immunoimaging
22k
Total downloads
70k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 16 Feb 2023
T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
doi 10.3389/fimmu.2023.1063838
- 4,932 views
- 15 citations
REVIEW
Published on 25 Jan 2023
Nanobodies in cell-mediated immunotherapy: On the road to fight cancer
doi 10.3389/fimmu.2023.1012841
- 10,449 views
- 24 citations
ORIGINAL RESEARCH
Published on 05 Dec 2022
Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
doi 10.3389/fmolb.2022.1039324
- 4,818 views
- 2 citations
ORIGINAL RESEARCH
Published on 23 Nov 2022
Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells
doi 10.3389/fimmu.2022.1006718
- 2,925 views
- 5 citations
REVIEW
Published on 08 Nov 2022
Applications of nanobodies in brain diseases
doi 10.3389/fimmu.2022.978513
- 9,725 views
- 29 citations
REVIEW
Published on 02 Nov 2022
Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors
doi 10.3389/fimmu.2022.1005800
- 4,299 views
- 4 citations
ORIGINAL RESEARCH
Published on 27 Oct 2022
CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
doi 10.3389/fimmu.2022.1010270
- 2,356 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Oct 2022
Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo
doi 10.3389/fimmu.2022.1012534
- 2,150 views
- 6 citations
REVIEW
Published on 13 Oct 2022
Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
doi 10.3389/fimmu.2022.1012806
- 4,353 views
- 15 citations
ORIGINAL RESEARCH
Published on 18 Aug 2022
Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling
doi 10.3389/fimmu.2022.980539
- 3,938 views
- 1 citation
ORIGINAL RESEARCH
Published on 28 Jun 2022
Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
doi 10.3389/fimmu.2022.885424
- 9,775 views
- 19 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Bioengineering and Biotechnology
- 4.3 impact factor
- 8.3 citescore
Frontiers in Molecular Biosciences
- 3.9 impact factor
- 7.2 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 70kTopic views
- 46kArticle views
- 22kArticle downloads